Skip to content

APOROTS: what changed

BE 0841.571.208NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-
2024 · €88,999-€88,999
Equity
€193,220
2024 · €246,310-€53,090
Cash
€36,310
2024 · €23,624+€12,686
Balance sheet total
€449,560
2024 · €516,306-€66,746

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€49,934

    down €49,934 (-36.3%), from €137,469 to €87,535

    of which Other amounts receivable: -€54,017

  • Tangible fixed assets -€18,149

    down €18,149 (-8.6%), from €211,143 to €192,994

    of which Land and buildings: -€11,106

  • Cash +€12,686

    up €12,686 (+53.7%), from €23,624 to €36,310

  • Stocks and contracts -€11,724

    down €11,724 (-9.8%), from €119,509 to €107,785

Equity and liabilities
  • Reserves -€53,090

    down €53,090 (-23.3%), from €227,710 to €174,620

    of which Distributable reserves: -€53,090

  • Tax, wage and social debts -€15,715

    down €15,715 (-47.8%), from €32,868 to €17,153

    of which Taxes: -€15,456

  • Trade debts +€9,540

    up €9,540 (+12.8%), from €74,382 to €83,922

  • Debts after one year -€8,202

    down €8,202 (-26.3%), from €31,193 to €22,991

Income statement
  • Gross operating margin -€163,714

    no longer reported in 2025; in 2024 it stood at €163,714

  • Staff costs -€30,516

    no longer reported in 2025; in 2024 it stood at €30,516

  • Taxes -€24,471

    no longer reported in 2025; in 2024 it stood at €24,471

  • Depreciation -€18,231

    no longer reported in 2025; in 2024 it stood at €18,231

  • Financial income -€4,128

    no longer reported in 2025; in 2024 it stood at €4,128

Change in the result, 2024 to 2025

effect on the result

The net result is not in both sets of accounts. Without it the difference cannot be explained line by line.

Derived cash bridge

cash 2024 to 2025

Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.

Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €516,306 €449,560 -€66,746 -12.9%
Fixed assets 21/28 €218,628 €200,478 -€18,149 -8.3%
Tangible fixed assets 22/27 €211,143 €192,994 -€18,149 -8.6%
Land and buildings 22 €164,796 €153,690 -€11,106 -6.7%
Furniture and vehicles 24 €1,003 €4,036 +€3,033 +302%
Leasing and similar rights 25 €45,343 €35,267 -€10,076 -22.2%
Financial fixed assets 28 €7,485 €7,485 = 0.0%
Current assets 29/58 €297,679 €249,082 -€48,597 -16.3%
Stocks and contracts in progress 3 €119,509 €107,785 -€11,724 -9.8%
Stocks 30/36 €119,509 €107,785 -€11,724 -9.8%
Amounts receivable within one year 40/41 €137,469 €87,535 -€49,934 -36.3%
Trade receivables 40 €39,155 €43,238 +€4,083 +10.4%
Other amounts receivable 41 €98,313 €44,297 -€54,017 -54.9%
Cash at bank and in hand 54/58 €23,624 €36,310 +€12,686 +53.7%
Deferred charges and accrued income 490/1 €17,077 €17,452 +€375 +2.2%
Total equity and liabilities 10/49 €516,306 €449,560 -€66,746 -12.9%
Equity 10/15 €246,310 €193,220 -€53,090 -21.6%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €227,710 €174,620 -€53,090 -23.3%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €225,850 €172,760 -€53,090 -23.5%
Amounts payable 17/49 €269,997 €256,341 -€13,656 -5.1%
Amounts payable after more than one year 17 €31,193 €22,991 -€8,202 -26.3%
Financial debts 170/4 €31,193 €22,991 -€8,202 -26.3%
Amounts payable within one year 42/48 €237,686 €232,017 -€5,669 -2.4%
Current portion of amounts payable after more than one year 42 €7,936 €8,202 +€266 +3.4%
Trade debts 44 €74,382 €83,922 +€9,540 +12.8%
Suppliers 440/4 €74,382 €83,922 +€9,540 +12.8%
Taxes, remuneration and social security 45 €32,868 €17,153 -€15,715 -47.8%
Taxes 450/3 €27,231 €11,774 -€15,456 -56.8%
Remuneration and social security 454/9 €5,637 €5,378 -€259 -4.6%
Other amounts payable 47/48 €122,500 €122,740 +€240 +0.2%
Accrued charges and deferred income 492/3 €1,118 €1,333 +€215 +19.2%
Remuneration, social security and pensions 62 €30,516 - -€30,516
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €18,231 - -€18,231
Other operating charges 640/8 €2,714 - -€2,714
Gross operating margin 9900 €163,714 - -€163,714
Operating profit (loss) 9901 €112,254 - -€112,254
Financial income 75/76B €4,128 - -€4,128
Recurring financial income 75 €4,128 - -€4,128
Financial charges 65/66B €2,913 - -€2,913
Recurring financial charges 65 €2,913 - -€2,913
Profit (loss) for the period before taxes 9903 €113,470 - -€113,470
Income taxes 67/77 €24,471 - -€24,471
Profit (loss) for the period 9904 €88,999 - -€88,999
Profit (loss) for the period to be appropriated 9905 €88,999 - -€88,999

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€385,306 to €500,785

Midpoint €433,422 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €193,220
Capitalised earnings €577,393 to €808,350
Indication €385,306 to €500,785

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€193,220
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€193,220

Capitalised earnings

net result for the year (9904)
2025
-
2024
€88,999
2023
€79,139
2022
€74,366
2021
€128,913
Average result
€80,835
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€577,393 / €673,625 / €808,350

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.